Washington, DC, June 16, 2004 — Ogilvy Public Relations Worldwide (Ogilvy PR) and Shire Health Group (Shire) have jointly established Fast4wD Ogilvy, a clinical trial recruitment and retention firm devoted to addressing the pharmaceutical industry’s need for global clinical trial support, Ogilvy PR CEO Marcia Silverman announced today. Fast4wD Ogilvy brings together the deep expertise in health communications and patient advocacy of Ogilvy PR’s Washington office with the extensive clinical trial support capability in Europe and Asia of Shire’s existing specialty company, Fast4wD, UK. The result says Silverman is “the first marketing company ever able to offer full specialized patient recruitment and retention support for clinical trials worldwide.”
Fast4wD Ogilvy will serve pharmaceutical companies who need global support for their worldwide clinical trials. More and more pharmaceutical companies are seeking to conduct their clinical trials both in the US and abroad. Until now, there has not been a company offering integrated clinical trial specialized recruitment and retention support across the world.
“There is a rapidly growing need which requires a seamless global approach,” Shire Health Group CEO Gloria Gibbons noted. “Several years ago the Shire Health Group, which is part of the Ogilvy PR Worldwide network, created Fast4wD, a specialized patient recruitment and retention clinical communications agency, with capability in Europe and Asia. Because of the success we have been experiencing in those markets, many of our clients have been asking for additional US solutions to meet their global needs. We are delighted to now be in a position to do just that.” Emma Sergeant, managing director of Fast4wD, UK, and president worldwide of the new venture said, “Pharmaceutical companies are experiencing significant delays in the clinical development process. The most significant bottleneck is due to difficulties with identifying, enrolling, and retaining suitable patients for the clinical trials required for product registration. Fast4wD Ogilvy’s global services have been set up to address this need.” According to Sergeant, “The Washington office of Ogilvy PR already had highly skilled staff with expertise in clinical trial recruitment as well as significant experience in social marketing, patient advocacy, and health communications. By combining that experience with Fast4wD’s proven track record, we can provide clients with the global solutions they are looking for.”
Silverman noted that the joint venture will allow Fast4wD Ogilvy to draw on the expertise and in-country capability of Ogilvy PR’s global network to help pharmaceutical companies reach their recruitment goals across the world. “Through the Ogilvy PR healthcare worldwide network, we are uniquely positioned to help pharmaceutical companies move rapidly through the patient recruitment bottleneck and retain participants in their studies.”
Fast4wD Ogilvy will maintain offices in Washington, DC and Oxford, UK. Chris Shreeve, Ogilvy PR senior vice president, will head up the Washington office. Michelle Argument will head the Europe/Asia office out of Oxford.
About the Shire Health Group
The Shire Health Group is a specialized Healthcare Communications group of companies based in Europe and the US. In 2003, the Shire Health Group joined the Ogilvy PR network strengthening the healthcare expertise. Over the last 18 years, the Shire Health Group has won many awards, including Communiqué agency of the year three times in the past six years, reflecting their success in International PR, medical education, advertising, consumer healthcare and clinical trial patient recruitment and retention.
About Ogilvy Public Relations Worldwide
Ogilvy Public Relations Worldwide is a global marketing communications firm, with offices in more than 60 cities around the world. Entering its 24th year providing public relations solutions, Ogilvy Public Relations Worldwide has specialties in consumer marketing, corporate (B2B), health & medical, social marketing, technology, public affairs, government relations and entertainment. Through its subsidiary Feinstein Kean Healthcare, Ogilvy Public Relations Worldwide provides communication consulting to biotechnology companies. The Holmes Report has named Ogilvy Public Relations Worldwide 2003 International Agency of the Year; marking the fourth consecutive year the firm has been awarded “Agency of the Year.” Ogilvy Public Relations Worldwide is part of the WPP Group, the world’s largest marketing communications company (NASDAQ: WPPGY, www.wpp.com). For more information, visit our Web site at www.ogilvypr.com.